Congo approves use of Ebola vaccination to fight outbreak

from Reuters - Thomson Reuters Foundation
Published on 29 May 2017 View Original

The rVSV-ZEBOV vaccine developed by Merck is not yet licensed but was shown to be highly protective against Ebola in clinical trials

By Aaron Ross

KINSHASA, May 29 (Reuters) - Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak in its northeast that has killed four people, a spokesman said on Monday.

Read more on Thomson Reuters Foundation.

Reuters - Thomson Reuters Foundation:

For more humanitarian news and analysis, please visit